0 items USD 0.00Search
- Did you mean
- closing spondylitis
Your search for "Ankylosing%20spondylitis" gave back 267 results.
Summary HeyReport estimates that the Tumor Necrosis Factor (TNF) Inhibitor Drugs market size will grow from xxx Million USD in 2020 to xxxx Million...
Catalog:
HYR
July 2021
Price: USD 2,000.00
Summary Publisher estimates that the Musculoskeletal Disorders Therapeutics market size will grow from xxx Million USD in 2020 to xxxx Million USD by...
Catalog:
HYR
April 2021
Price: USD 2,000.00
Summary The Musculoskeletal Disorders Therapeutics market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of...
Catalog:
HYR
March 2021
Price: USD 2,000.00
Axial Spondyloarthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct...
Catalog:
Global Markets Direct
October 2022
Price: USD 2,000.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Humira market size was valued at US$ 16700 million in 2023. With growing demand in downstream market, the Humira is forecast to a...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
GIR
April 2023
Price: USD 3,480.00
The global Biosimilar Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Etanercept, sold under the brand name Enbrel among others, is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Enbrel is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Remicade (Infliximab) and Biosimilar market size is projected to grow from US$ 2494.5 million in 2022 to US$ 3703.9 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Axial Spondyloarthritis - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
May 2018
Price: USD 2,000.00
